{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:06:50Z","timestamp":1788527210984,"version":"build-2803163510"},"reference-count":28,"publisher":"SLACK, Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:p>Hemoglobinopathies are inherited disorders of hemoglobin structure or production. Sickle cell disease (SCD) results from a beta-globin mutation causing hemoglobin polymerization, red blood cell sickling, vaso-occlusion, and hemolytic anemia. Thalassemia results from reduced or absent alpha- or beta-globin synthesis, ranging from asymptomatic carrier states to transfusion-dependent anemia. This article summarizes the pathophysiology, diagnosis, management, and curative options for SCD and transfusion-dependent thalassemia, emphasizing allogeneic hematopoietic stem cell transplantation and approved gene therapies. We discuss indications, counseling, barriers to access, toxicity, donor availability, fertility counseling, and comparative features of cellular therapies. Advances in transplantation, gene addition, and gene editing may expand access to curative-intent therapy and improve outcomes for selected patients.<\/jats:p>","DOI":"10.3928\/19382359-20260629-01","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:53:25Z","timestamp":1788486805000},"source":"Crossref","is-referenced-by-count":1,"title":["Hemoglobinopathies and Cellular Therapy: What Pediatricians Need to Know About Indications and Counseling"],"prefix":"10.3928","volume":"55","author":[{"given":"Obadah","family":"Alquadan","sequence":"first","affiliation":[{"name":"Hurley Children's Hospital, Division of Pediatrics, Flint"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Deebaja","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Pediatric Blood and Marrow Transplantation Program, Barbara Ann Karmanos Cancer Center, Children's Hospital of Michigan, Detroit"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Mount Pleasant, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanti","family":"Gupte","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Pediatric Blood and Marrow Transplantation Program, Barbara Ann Karmanos Cancer Center, Children's Hospital of Michigan, Detroit"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Mount Pleasant, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman T.","family":"Al-Antary","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology, Pediatric Blood and Marrow Transplantation Program, Barbara Ann Karmanos Cancer Center, Children's Hospital of Michigan, Detroit"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Mount Pleasant, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","volume-title":"GeneReviews\u00ae [Internet]","author":"Bender MA","year":"1993","unstructured":"Bender MA, Carlberg K. Sickle cell disease. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews\u00ae [Internet]. University of Washington, Seattle; 1993. [updated 2025 Feb 13] PMID:20301551"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17312"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.10233"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035237"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7599.2009.00401.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.10517"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2405"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31822-6"},{"issue":"4","key":"e_1_3_1_10_2","first-page":"339","article-title":"Alpha and beta thalassemia","volume":"80","author":"Muncie HL","year":"2009","unstructured":"Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339\u2013344. PMID:19678601","journal-title":"Am Fam Physician"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1590\/1519-6984.246062"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.066845"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-11"},{"key":"e_1_3_1_14_2","volume-title":"StatPearls","author":"Motiani A","year":"2024","unstructured":"Motiani A, Zubair M, Sonagra AD. Laboratory evaluation of alpha thalassemia. In: StatPearls. StatPearls Publishing; February 9, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK587402\/"},{"issue":"3","key":"e_1_3_1_15_2","first-page":"272","article-title":"Alpha- and Beta-thalassemia: rapid evidence review","volume":"105","author":"Baird DC","year":"2022","unstructured":"Baird DC, Batten SH, Sparks SK. Alpha- and Beta-thalassemia: rapid evidence review. Am Fam Physician. 2022;105(3):272\u2013280. PMID:35289581","journal-title":"Am Fam Physician"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000296"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2009.015"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198409203111207"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15030713"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309676"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26741"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014104"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011825"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000732"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004394C"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10483.x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7299-9_5"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-489112"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2017.05.009"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:53:27Z","timestamp":1788486807000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/19382359-20260629-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.3928\/19382359-20260629-01"],"URL":"https:\/\/doi.org\/10.3928\/19382359-20260629-01","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}